854 Followers on Owler

Intellia Therapeutics

is a Massachusetts-based biotechnology company that researches and develops genome editing therapies to treat genetic and oncological diseases... Read more
OverviewCompetitorsAcquisitionsFundingInvestmentsNews & Insights

Intellia Therapeutics

is a Massachusetts-based biotechnology company that researches and develops genome editing therapies to treat genetic and oncological diseases... Read more
Intellia Therapeutics President & CEO: John Leonard

President & CEO

John Leonard

CEO Approval Rating

81/100

2014

PublicNASDAQNTLA

Pharmaceuticals & Biotechnology
Biotechnology
2836 NAICS listing

Annual Revenue
$66.1M
Employees
600
Funding
$883.6M
Acquisitions
1
Investments
2

News

Funding
Aug 21, 2025
Seeking Alpha
Intellia received $560K in Post-IPO Equity Funding

Intellia Therapeutics Competitors

1Beam
2CRISPR
3Caribou
4Editas Medicine
5ToolGen
6Allogene
7bluebird bio
8Cellectis
Unlock 5 + competitors

Trending Companies